Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
7 hedge funds and large institutions have $12.1M invested in Apollo Endosurgery, Inc. in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
30% less funds holding
Funds holding: 10 → 7 (-3)
44% less capital invested
Capital invested by funds: $21.5M → $12.1M (-$9.38M)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$40.8K |
| 2 |
BlackRock
New York
|
+$22.9K |
| 3 |
RWA
Ropes Wealth Advisors
Boston,
Massachusetts
|
+$14.7K |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$702 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$857K |
| 2 |
TAF
Tredje AP-fonden
Se-111 91 Stockholm,
Sweden
|
-$851K |
| 3 |
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
-$148K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$13K |
APEN Hedge Fund Activity: Q2 2017 in Review
7 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q2 2017, worth a combined $12.1M — down 44% from $21.5M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of APEN and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was Bridgeway Capital Management, adding an estimated $40.8K. The largest seller was Novo Holdings A/S, cutting an estimated $857K.
- 7 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q2 2017, down from 10 in Q1 2017.
- Funds reported $12.1M of Apollo Endosurgery, Inc. stock for Q2 2017, down 44% quarter-over-quarter.
- 1 fund opened new Apollo Endosurgery, Inc. positions in Q2 2017 and 4 closed out, a net change of -3 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q2 2017 was Bridgeway Capital Management, an estimated $40.8K added.
- The largest Apollo Endosurgery, Inc. seller in Q2 2017 was Novo Holdings A/S, an estimated $857K sold.
Based on aggregated 13F filings for Q2 2017.